Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pharming Group N.V. Sponsored ADR (PHAR) had Revenue of $106.54M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$106.54M
Net Income	$5.47M
Cost of Goods Sold	$21.08M
Gross Profit	$85.46M
Operating Expenses	$100.25M
Operating Income	$6.29M
Non-Operating Income/Expense	$-1.45M
Pre-Tax Income	$4.83M
Normalized Pre-Tax Income	$4.83M
Income after Taxes	$5.33M
Income from Continuous Operations	$5.33M
Consolidated Net Income/Loss	$5.33M
Normalized Income after Taxes	$5.33M
EBIT	$6.29M
EBITDA	$9.49M
Weighted-Average Shares Outstanding (Basic)	68.88M
Weighted-Average Shares Outstanding (Diluted)	74.69M
Earnings per Share (EPS) (Basic)	$0.08
Earnings per Share (EPS) (Diluted)	$0.10
Balance Sheet Financials
Current Assets	$299.47M
Property, Plant, and Equipment	$7.23M
Long-Term Assets	$200.49M
Total Assets	$499.96M
Current Liabilities	$115.79M
Long-Term Debt	$92.72M
Long-Term Liabilities	$107.07M
Total Liabilities	$222.86M
Common Equity	$277.10M
Tangible Shareholders Equity	$141.56M
Shareholders Equity	$277.10M
Common Shares Outstanding	70.17M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$54.71M
Cash Flow from Investing Activities	$26.25M
Cash Flow from Financial Activities	$1.50M
Beginning Cash	$54.94M
End Cash	$145.31M
Increase/Decrease in Cash	$90.36M
Stock-Based Compensation	$13.77M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.59
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.25
Debt to Equity Ratio	0.35
Gross Margin	80.22%
Operating Margin	5.90%
EBIT Margin	5.90%
EBITDA Margin	--
Pre-Tax Profit Margin	4.54%
Profit Margin	5.13%
Free Cash Flow	$53.96M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.32
Receiveable Turnover	1.95
Days Sales in Receivables	46.21
Return on Equity	1.92%
Return on Tangible Equity	3.76%
Return on Assets	1.07%
Return on Investments	1.44%
Book Value Per Share	$3.95
Free Cash Flow per Share	$0.72
Operating Cash Flow per Share	$0.73

Data from Zacks Investment Research, Inc.